WhyOSA
AI-powered platform that matches sleep apnea patients to the right treatment.
Company Overview
Snapshot
Founded in March 2026 by Ran Manevich and Shahar Levi, WhyOSA operates with 1–10 employees. The company has secured funding across one round from one investor, ICI Fund, to advance its AI-powered platform for sleep apnea treatment.
Business overview
WhyOSA develops a clinical decision-support platform for obstructive sleep apnea (OSA). This solution integrates patient data, clinical evidence, and AI models to assist physicians in identifying the most suitable treatment for each patient, thereby minimizing trial-and-error in therapy selection. The platform aims to enhance patient outcomes, improve therapy adherence, and streamline clinical workflows for sleep medicine providers and healthcare organizations within the Health Tech & Life Sciences sector, specifically focusing on Medical Devices.
Log in to access full profile ›Company Intelligence Q&A
- What is WhyOSA's primary focus?
- WhyOSA focuses on developing a clinical decision-support platform for obstructive sleep apnea (OSA), utilizing AI to match patients with appropriate treatments.
- When was WhyOSA founded?
- WhyOSA was founded in March 2026.
- Who are the founders of WhyOSA?
- WhyOSA was founded by Ran Manevich and Shahar Levi.
- What is the current employee size of WhyOSA?
- WhyOSA currently has 1–10 employees.